Former Executive Chair of the Board of Directors · Climb Bio, Inc. (CLYM)

Andrew Levin

FY2024 is the first fiscal year CompBrief holds for Andrew Levin as a named executive officer of Climb Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$124,205

Salary $0Stock awards $0

4th of 4 named executive officers at Climb Bio by FY2024 total.

4 named officers on file for Climb Bio, FY2024

Andrew Levin’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Climb Bio’s whole pay program stands against its peers

  • Climb Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLYM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Andrew Levin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Andrew Levin compensation by year

Climb Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Climb Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$0
Bonus$0
Stock awards$0
Option awards$63,622
Non-equity incentive$0
Pension and deferred compensation$0
All other$60,583
Total$124,205

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Climb Bio, Inc. DEF 14A filed April 25, 2025, accession 0001193125-25-096697, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Climb Bio, Inc. filed document, accession 0001193125-25-096697. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option10,000—$7.89

Per the Outstanding Equity Awards at Fiscal Year-End table in Climb Bio, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Climb Bio’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Aoife BrennanPresident and Chief Executive Officer$6,019,892
Brett KaplanFormer Chief Operating Officer$2,989,468
Valerie MorissetFormer Executive Vice President, Research and Development and Chief Scientific Officer$2,235,295
Andrew Levin · this pageFormer Executive Chair of the Board of Directors$124,205

Board service

Climb Bio board · FY2021–FY2025
Director compensation in US dollars, as Climb Bio reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$38,871—$40,252—$79,123
FY2024$60,583$0$63,622$0$124,205
FY2022$73,000—$23,336—$96,336
FY2021$28,258—$165,566—$193,824

Each year as the company reported it in Climb Bio's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Climb Bio pays directors a $40,000 cash retainer. As stated in Climb Bio's FY2025 proxy.

Committees

Audit · Compensation · Nominating/Governance

The full Climb Bio compensation record

free company brief

This page is one person within Climb Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Climb Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrew Levin's compensation dossier · One-time report. No refunds.